NM_170692.4:c.202+78379G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_170692.4(RASAL2):c.202+78379G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.262 in 151,950 control chromosomes in the GnomAD database, including 6,225 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.26 ( 6225 hom., cov: 32)
Consequence
RASAL2
NM_170692.4 intron
NM_170692.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.06
Publications
5 publications found
Genes affected
RASAL2 (HGNC:9874): (RAS protein activator like 2) This gene encodes a protein that contains the GAP-related domain (GRD), a characteristic domain of GTPase-activating proteins (GAPs). GAPs function as activators of Ras superfamily of small GTPases. The protein encoded by this gene is able to complement the defective RasGAP function in a yeast system. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.342 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RASAL2 | NM_170692.4 | c.202+78379G>A | intron_variant | Intron 1 of 17 | ENST00000367649.8 | NP_733793.2 | ||
| RASAL2 | NM_001437625.1 | c.202+78379G>A | intron_variant | Intron 1 of 18 | NP_001424554.1 | |||
| RASAL2 | NM_001437626.1 | c.202+78379G>A | intron_variant | Intron 1 of 17 | NP_001424555.1 | |||
| RASAL2 | NM_001437627.1 | c.202+78379G>A | intron_variant | Intron 1 of 18 | NP_001424556.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.262 AC: 39846AN: 151830Hom.: 6228 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
39846
AN:
151830
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.262 AC: 39841AN: 151950Hom.: 6225 Cov.: 32 AF XY: 0.263 AC XY: 19569AN XY: 74270 show subpopulations
GnomAD4 genome
AF:
AC:
39841
AN:
151950
Hom.:
Cov.:
32
AF XY:
AC XY:
19569
AN XY:
74270
show subpopulations
African (AFR)
AF:
AC:
3762
AN:
41492
American (AMR)
AF:
AC:
3575
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
AC:
1196
AN:
3464
East Asian (EAS)
AF:
AC:
1373
AN:
5164
South Asian (SAS)
AF:
AC:
1158
AN:
4808
European-Finnish (FIN)
AF:
AC:
4266
AN:
10556
Middle Eastern (MID)
AF:
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23507
AN:
67904
Other (OTH)
AF:
AC:
578
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1436
2872
4309
5745
7181
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
410
820
1230
1640
2050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
776
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.